Islamabad: The National Institute of Health (NIH) Islamabad has ‘advised’ the Drug Regulatory Authority of Pakistan (DRAP) to ensure the availability of Diphtheria Antitoxin in the country following the deaths of dozens of children throughout the country due to diphtheria.

Diphtheria is a vaccine-preventable disease caused by strains of a bacterium called ‘Corynebacterium diphtheria’ that make toxins.

It can lead to breathing, heart rhythm problems, and even death.

Pakistani children are given a vaccine, a combination of five vaccines that protects from five major diseases: diphtheria, tetanus, pertussis (whooping cough), hepatitis B and Haemophilus influenza type b (DTP-hepB-Hib), The News International.

Over 45 children and teenagers lost their lives due to diphtheria across Pakistan in 2022 while hundreds of suspected cases have been reported from Sindh, Balochistan, Punjab and Khyber Pakhtunkhwa as well as Azad Kashmir and Gilgit-Baltistan, officials say the Ministry of National Health Services, Regulations and Coordination (NHS,R&C) said and blamed the poor quality of vaccination for the resurgence of diphtheria, which has been wiped out from most parts of the world, the newspaper reported.

According to an NIH Advisory titled “Advisory for Prevention and Treatment of Corynebacterium diphtheria”, the infectious disease diphtheria is a potentially life-threatening bacterial disease caused by infection with toxin-producing strains of Corynebacterium diphtheria.

“In Pakistan, sporadic cases of diphtheria continue to be reported and are usually prevalent from November to February. In 2022, there were 26 laboratory-confirmed cases.